CC Pharma GmbH secures contract for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient ranibizumab, ATC S01LA04 for the period 01092024 - 31082026

Germany, Sept. 25 -- Germany based CC Pharma GmbH has secured contract from DAK-Gesundheit for Pharmaceutical products - Conclusion of a non-exclusive discount agreement in accordance with Section 130a Paragraph 8 SGB V for the active ingredient ranibizumab, ATC S01LA04 for the period 01092024 - 31082026 . The value of the contract is not disclosed .

Published by HT Digital Content Services with permission from Pivotal Sources....